Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced / Metastatic Solid Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT05074472
What this trial is testing

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Who this might be right for
Solid Tumor, AdultPancreatic Ductal; AdenocarcinomaOvarian Serous Adenocarcinoma+2 more
ZielBio, Inc. 35
Early research (Phase 1)Study completedNCT04511845
What this trial is testing

A Dose-Escalation Study of SPYK04 in Patients With Locally Advanced or Metastatic Solid Tumors (With Expansion).

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Chugai Pharmaceutical 85
Early research (Phase 1)Study completedNCT01625156
What this trial is testing

Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612137
What this trial is testing

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Innovent Biologics (Suzhou) Co. Ltd. 282
Early research (Phase 1)UnknownNCT05407909
What this trial is testing

To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 176
Early research (Phase 1)Study completedNCT05867121
What this trial is testing

Evaluate Safety, Pharmacokinetics, & Activity of RO7496353 in Combination With a Checkpoint Inhibitor With or Without Standard-of-care Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors; Urothelial Carcinoma Substudy in Association With RO7496353 Study GO44010

Who this might be right for
Non-small Cell Lung CancerGastric CancerPancreatic Ductal Adenocarcinoma
Genentech, Inc. 102
Testing effectiveness (Phase 2)Ended earlyNCT05798611
What this trial is testing

Study of ART0380 in Patients With Biologically Selected Solid Tumors

Who this might be right for
Advanced Solid TumorRecurrent Endometrial CancerMetastatic Cancer
Artios Pharma Ltd 36
Not applicableEnded earlyNCT01904916
What this trial is testing

CPCT-05 Biopsy Protocol Patient Selection

Who this might be right for
Solid TumorsMetastatic Disease
P.O. Witteveen 195
Early research (Phase 1)Study completedNCT00638898
What this trial is testing

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

Who this might be right for
Solid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more
City of Hope Medical Center 25
Testing effectiveness (Phase 2)Study completedNCT04761198
What this trial is testing

Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

Who this might be right for
Solid Tumor, AdultAdvanced Solid TumorMetastatic Solid Tumor
Mereo BioPharma 76
Testing effectiveness (Phase 2)Looking for participantsNCT05956587
What this trial is testing

SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 121
Early research (Phase 1)Looking for participantsNCT05631964
What this trial is testing

Phase I Clinical Study of BL-M07D1 in Locally Advanced or Metastatic Digestive Tract Tumors and Other Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Digestive Tract TumorsOther Solid Tumors
Sichuan Baili Pharmaceutical Co., Ltd. 26
Early research (Phase 1)UnknownNCT06013111
What this trial is testing

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors

Who this might be right for
Carcinoma
China Medical University, China 9
Testing effectiveness (Phase 2)Study completedNCT01588821
What this trial is testing

Cabozantinib in Advanced Solid Malignancies

Who this might be right for
Lung CancerSolid Tumor (Not Breast or Prostate Cancers)
Massachusetts General Hospital 37
Early research (Phase 1)Study completedNCT05116709
What this trial is testing

Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Bio-Thera Solutions 28
Testing effectiveness (Phase 2)Looking for participantsNCT05898399
What this trial is testing

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
Artios Pharma Ltd 181
Testing effectiveness (Phase 2)Active Not RecruitingNCT05949619
What this trial is testing

BL-M02D1 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 14
Early research (Phase 1)Study completedNCT03944499
What this trial is testing

Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.

Who this might be right for
Solid TumorBreast Cancer
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 161
Early research (Phase 1)Study completedNCT00390936
What this trial is testing

BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Bristol-Myers Squibb 13
Next Page